Preclinical dose response study shows NR2E3 can attenuate retinal degeneration in the retinitis pigmentosa mouse model RhoP23H+/−

Gene Therapy, Published online: 26 January 2024; doi:10.1038/s41434-024-00440-6Preclinical dose response study shows NR2E3 can attenuate retinal degeneration in the retinitis pigmentosa mouse model RhoP23H+/−

https://www.nature.com/articles/s41434-024-00440-6

Source: Gene Therapy - January 26, 2024 Category: Genetics & Stem Cells Authors: Shannon M. McNamee Natalie P. Chan Monica Akula Marielle O. Avola Maiya Whalen Kaden Nystuen Pushpendra Singh Arun K. Upadhyay Margaret M. DeAngelis Neena B. Haider Source Type: research

More News: Gene Therapy | Genetics | Retinitis Pigmentosa | Study | Vitamin A